These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 17134822)
21. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Pietersen AM; Horlings HM; Hauptmann M; Langerød A; Ajouaou A; Cornelissen-Steijger P; Wessels LF; Jonkers J; van de Vijver MJ; van Lohuizen M Breast Cancer Res; 2008; 10(6):R109. PubMed ID: 19099573 [TBL] [Abstract][Full Text] [Related]
22. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors. Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557 [TBL] [Abstract][Full Text] [Related]
23. The polycomb group protein EED interacts with YY1, and both proteins induce neural tissue in Xenopus embryos. Satijn DP; Hamer KM; den Blaauwen J; Otte AP Mol Cell Biol; 2001 Feb; 21(4):1360-9. PubMed ID: 11158321 [TBL] [Abstract][Full Text] [Related]
24. Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. Dukers DF; van Galen JC; Giroth C; Jansen P; Sewalt RG; Otte AP; Kluin-Nelemans HC; Meijer CJ; Raaphorst FM Am J Pathol; 2004 Mar; 164(3):873-81. PubMed ID: 14982841 [TBL] [Abstract][Full Text] [Related]
26. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma. Vékony H; Raaphorst FM; Otte AP; van Lohuizen M; Leemans CR; van der Waal I; Bloemena E J Clin Pathol; 2008 Jun; 61(6):744-9. PubMed ID: 18326020 [TBL] [Abstract][Full Text] [Related]
27. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells. Aoki R; Chiba T; Miyagi S; Negishi M; Konuma T; Taniguchi H; Ogawa M; Yokosuka O; Iwama A J Hepatol; 2010 Jun; 52(6):854-63. PubMed ID: 20395008 [TBL] [Abstract][Full Text] [Related]
28. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Balasubramanian S; Adhikary G; Eckert RL Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867 [TBL] [Abstract][Full Text] [Related]
29. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells. Vandamme J; Völkel P; Rosnoblet C; Le Faou P; Angrand PO Mol Cell Proteomics; 2011 Apr; 10(4):M110.002642. PubMed ID: 21282530 [TBL] [Abstract][Full Text] [Related]
30. Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors. Sánchez-Beato M; Sánchez E; García JF; Pérez-Rosado A; Montoya MC; Fraga M; Artiga MJ; Navarrete M; Abraira V; Morente M; Esteller M; Koseki H; Vidal M; Piris MA J Pathol; 2004 Dec; 204(5):528-37. PubMed ID: 15470680 [TBL] [Abstract][Full Text] [Related]
31. The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens. Steele JC; Torr EE; Noakes KL; Kalk E; Moss PA; Reynolds GM; Hubscher SG; van Lohuizen M; Adams DH; Young LS Br J Cancer; 2006 Nov; 95(9):1202-11. PubMed ID: 17024127 [TBL] [Abstract][Full Text] [Related]
32. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma. Ha SY; Kim SH Pathol Res Pract; 2012 Aug; 208(8):462-9. PubMed ID: 22766604 [TBL] [Abstract][Full Text] [Related]
33. Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features. Wang W; Lin T; Huang J; Hu W; Xu K; Liu J Urol Oncol; 2011; 29(3):244-51. PubMed ID: 19395284 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters. Melling N; Thomsen E; Tsourlakis MC; Kluth M; Hube-Magg C; Minner S; Koop C; Graefen M; Heinzer H; Wittmer C; Sauter G; Wilczak W; Huland H; Simon R; Schlomm T; Steurer S; Krech T Carcinogenesis; 2015 Nov; 36(11):1333-40. PubMed ID: 26392259 [TBL] [Abstract][Full Text] [Related]
35. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer. Saramäki OR; Tammela TL; Martikainen PM; Vessella RL; Visakorpi T Genes Chromosomes Cancer; 2006 Jul; 45(7):639-45. PubMed ID: 16575874 [TBL] [Abstract][Full Text] [Related]
36. Polycomb group gene silencing proteins are concentrated in the perichromatin compartment of the mammalian nucleus. Cmarko D; Verschure PJ; Otte AP; van Driel R; Fakan S J Cell Sci; 2003 Jan; 116(Pt 2):335-43. PubMed ID: 12482919 [TBL] [Abstract][Full Text] [Related]
37. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. Rhodes DR; Sanda MG; Otte AP; Chinnaiyan AM; Rubin MA J Natl Cancer Inst; 2003 May; 95(9):661-8. PubMed ID: 12734317 [TBL] [Abstract][Full Text] [Related]
38. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention. Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N J Virol; 2019 May; 93(9):. PubMed ID: 30814291 [TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration. Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997 [TBL] [Abstract][Full Text] [Related]
40. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression. Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]